Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$117.13 - $176.59 $3.73 Million - $5.62 Million
-31,848 Reduced 89.46%
3,752 $535,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $3.73 Million - $5.62 Million
-31,848 Reduced 89.46%
3,752 $536,000
Q1 2022

Sep 21, 2023

SELL
$126.46 - $235.05 $3.26 Million - $6.06 Million
-25,800 Reduced 42.02%
35,600 $6.13 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $3.26 Million - $6.06 Million
-25,800 Reduced 42.02%
35,600 $6.13 Million
Q4 2021

Sep 21, 2023

SELL
$225.82 - $368.51 $6.65 Million - $10.9 Million
-29,467 Reduced 32.43%
61,400 $15.6 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $6.65 Million - $10.9 Million
-29,467 Reduced 32.43%
61,400 $15.6 Million
Q3 2021

Sep 21, 2023

BUY
$221.9 - $484.47 $9.79 Million - $21.4 Million
44,104 Added 94.31%
90,867 $35 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $9.79 Million - $21.4 Million
44,104 Added 94.31%
90,867 $35 Million
Q2 2021

Sep 21, 2023

BUY
$129.91 - $234.98 $1.3 Million - $2.35 Million
9,999 Added 27.2%
46,763 $11 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1.3 Million - $2.35 Million
9,999 Added 27.2%
46,763 $11 Million
Q1 2021

Sep 21, 2023

BUY
$109.18 - $185.98 $410,953 - $700,028
3,764 Added 11.41%
36,764 $4.81 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $410,953 - $700,028
3,764 Added 11.41%
36,764 $4.81 Million
Q4 2020

Sep 21, 2023

BUY
$65.74 - $169.86 $2.17 Million - $5.61 Million
33,000 New
33,000 $3.45 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.75 Million - $4.52 Million
26,606 Added 416.11%
33,000 $3.45 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $347,449 - $606,470
6,394 New
6,394 $452,000
Q4 2019

Feb 13, 2020

SELL
$13.93 - $21.28 $1.13 Million - $1.72 Million
-81,034 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$12.26 - $18.07 $213,863 - $315,213
17,444 Added 27.43%
81,034 $1.29 Million
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $871,183 - $1.8 Million
63,590 New
63,590 $931,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.